Stockscreener 앱 받기
0.19
3.60%
0.0066
시간 외 거래:
.18
-0.01
-5.26%
전일 마감가:
$0.1834
열려 있는:
$0.1779
하루 거래량:
1.20M
Relative Volume:
0.13
시가총액:
$13.67M
수익:
-
순이익/손실:
$-88.35M
주가수익비율:
-0.1419
EPS:
-1.3391
순현금흐름:
$-81.07M
1주 성능:
-14.34%
1개월 성능:
-47.30%
6개월 성능:
-87.82%
1년 성능:
-78.89%
1일 변동 폭
$0.17
$0.194
1주일 범위
$0.1402
$0.238
52주 변동 폭
$0.1402
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
명칭
Io Biotech Inc
전화
(457) 070-2980
주소
OLE MAALOES VEH 3, COPENHAGEN
Compare IOBT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.19 | 13.20M | 0 | -88.35M | -81.07M | -1.3391 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-26 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2026-01-08 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2025-09-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | 다운그레이드 | TD Cowen | Buy → Hold |
Io Biotech Inc 주식(IOBT)의 최신 뉴스
Is Haverty Furniture Companies Inc part of any major index2026 PostEarnings & Real-Time Volume Triggers - baoquankhu1.vn
Layoff Tracker: Inovio Slims Down as Lead Asset Nears Market - BioSpace
IOBT Stock Price and Chart — NASDAQ:IOBT - TradingView
Market Overview: Is IO Biotech Inc stock a smart retirement pickEarnings Performance Report & Smart Swing Trading Techniques - baoquankhu1.vn
IO Biotech, Inc. (NASDAQ:IOBT) Sees Large Decline in Short Interest - Defense World
IOBT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
IOBT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Portfolio Update: Is IO Biotech Inc stock a smart retirement pick2025 Support & Resistance & Consistent Profit Trading Strategies - baoquankhu1.vn
IO Biotech receives Nasdaq notice for bid price noncompliance - MSN
Is IO Biotech Inc. stock attractive for ETFs2025 Earnings Surprises & Low Risk Entry Point Tips - mfd.ru
Cancer Vaccines Competitive Landscape Report 2026: Comprehensive Insights About 250+ Companies and 300+ DrugsCollaborations and Licensing by Key Players Like Moderna, Merck, and IO Biotech - Yahoo Finance
Will IO Biotech Inc. outperform its industry peers2025 Key Lessons & Verified Chart Pattern Signals - mfd.ru
Chart Watch: Will IO Biotech Inc outperform tech stocksBuy Signal & Fast Exit Strategy with Risk Control - baoquankhu1.vn
IOBT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
IOBT PE Ratio & Valuation, Is IOBT Overvalued - Intellectia AI
IO Biotech Faces Nasdaq Noncompliance, Potential Delisting Risk - TipRanks
IO Biotech Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns IO Biotech (NASDAQ: IOBT) on $50M market value rule - Stock Titan
Here's why IO Biotech, Inc. (IOBT) looks ripe for bottom fishing - MSN
Here's Why IO Biotech, Inc. (IOBT) Looks Ripe for Bottom Fishing - Finviz
Is IO Biotech Inc. a top pick in the sectorJuly 2025 Catalysts & Short-Term High Return Ideas - mfd.ru
Guidance Update: Is IO Biotech Inc in a consolidation phaseJuly 2025 PostEarnings & Safe Capital Growth Tips - baoquankhu1.vn
Point72 discloses 5.6% IO Biotech (IOBT) ownership stake - Stock Titan
Fierce Biotech Layoff Tracker 2026: ARPA-H makes cuts; GSK trims R&D team - Fierce Biotech
IO Biotech Provides Corporate Update - marketscreener.com
IO Biotech, Inc. (NASDAQ:IOBT) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
IO Biotech (IOBT) launches restructuring, CMO exit and up to $2.6M charges - Stock Titan
IO Biotech hires Raymond James as advisor, cuts workforce By Investing.com - Investing.com Canada
IO Biotech Engages Raymond James as Financial Advisor Amid Workforce Reduction and Cost-Containment Measures - Quiver Quantitative
Cancer vaccine maker IO Biotech cuts staff, hires Raymond James - Stock Titan
Piper downgrades IO Biotech amid strategic alternatives evaluation - Yahoo Finance
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review By Investing.com - Investing.com South Africa
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review - Investing.com South Africa
Piper Sandler Downgrades IO Biotech (IOBT) to Neutral, Lowers Pr - GuruFocus
Piper Sandler Downgrades IO Biotech to Neutral From Overweight, Adjusts Price Target to $0.50 From $3 - marketscreener.com
IO Biotech stock rating downgraded by Piper Sandler amid strategic review - Investing.com South Africa
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why - MSN
Aug Decliners: Is IO Biotech Inc a potential multi baggerMarket Growth Report & Entry and Exit Point Strategies - baoquankhu1.vn
IOBT IO Biotech, Inc. (NASDAQ) $0.47 on 22 Jan 2026: active intraday mover for traders - Meyka
IO Biotech’s Future Uncertain As Cylembio Cloud Remains - Citeline News & Insights
IO Biotech Begins Review Of Strategic Options As Cash Runway Narrows - Nasdaq
IO Biotech weighs strategic options months after FDA advises against melanoma vaccine filing - European Biotechnology Magazine
IO Biotech admits defeat | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Listed Danish biotech company fights for survival after FDA rejection and failed capital raising - medwatch.com
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - intellectia.ai
Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow - Nasdaq
IO Biotech stock plummets after company explores strategic alternatives By Investing.com - Investing.com Nigeria
IO Biotech stock plummets after company explores strategic alternatives - Investing.com
IO Biotech announces exploration of strategic alternatives - TipRanks
IO mulls more layoffs months after halving head count in wake of cancer vaccine setback - Fierce Biotech
IO Biotech Explores Strategic Alternatives Amid Cost-Cutting Plans - TipRanks
Io Biotech Inc (IOBT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):